Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,618 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation.
Wada F, Kanda J, Kamijo K, Nishikubo M, Yoshioka S, Ishikawa T, Ueda Y, Akasaka T, Arai Y, Izumi K, Hirata H, Ikeda T, Yonezawa A, Anzai N, Watanabe M, Imada K, Yago K, Tamura N, Itoh M, Masuo Y, Kunitomi A, Takeoka T, Kitano T, Arima N, Hishizawa M, Asagoe K, Kondo T, Takaori-Kondo A. Wada F, et al. Among authors: kondo t. Cell Transplant. 2023 Jan-Dec;32:9636897231194497. doi: 10.1177/09636897231194497. Cell Transplant. 2023. PMID: 37646153 Free PMC article.
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation.
Shibata S, Arai Y, Kondo T, Mizuno S, Harada K, Miyakoshi S, Uchida N, Maruyama Y, Eto T, Katsuoka Y, Matsue K, Nishiwaki K, Takada S, Doki N, Itoh M, Nagafuji K, Kawakita T, Tanaka J, Fukuda T, Atsuta Y, Yanada M. Shibata S, et al. Among authors: kondo t. Transplant Cell Ther. 2023 May;29(5):332.e1-332.e11. doi: 10.1016/j.jtct.2023.02.004. Epub 2023 Feb 14. Transplant Cell Ther. 2023. PMID: 36796517 Free article.
Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy.
Morita-Fujita M, Shindo T, Iemura T, Arai Y, Kanda J, Okada K, Ueda Y, Yoshiyuki O, Anzai N, Mori T, Ishikawa T, Otsuka Y, Yonezawa A, Yuhi N, Imada K, Oba A, Itoh M, Okamoto Y, Kitano T, Ikeda T, Kotani S, Akasaka T, Yago K, Watanabe M, Nohgawa M, Tsuji M, Takeoka T, Yamamoto R, Arima N, Yoshinaga N, Hishizawa M, Yamashita K, Kondo T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group. Morita-Fujita M, et al. Among authors: kondo t. Transplant Cell Ther. 2023 Jun;29(6):347.e1-347.e11. doi: 10.1016/j.jtct.2023.03.002. Epub 2023 Mar 6. Transplant Cell Ther. 2023. PMID: 36889508
A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Jo T, Arai Y, Kanda J, Kondo T, Ikegame K, Uchida N, Doki N, Fukuda T, Ozawa Y, Tanaka M, Ara T, Kuriyama T, Katayama Y, Kawakita T, Kanda Y, Onizuka M, Ichinohe T, Atsuta Y, Terakura S. Jo T, et al. Among authors: kondo t. Commun Med (Lond). 2023 May 16;3(1):67. doi: 10.1038/s43856-023-00299-5. Commun Med (Lond). 2023. PMID: 37193882 Free PMC article.
Author Correction: A convolutional neural network-based model that predicts acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Jo T, Arai Y, Kanda J, Kondo T, Ikegame K, Uchida N, Doki N, Fukuda T, Ozawa Y, Tanaka M, Ara T, Kuriyama T, Katayama Y, Kawakita T, Kanda Y, Onizuka M, Ichinohe T, Atsuta Y, Terakura S. Jo T, et al. Among authors: kondo t. Commun Med (Lond). 2023 Jun 22;3(1):89. doi: 10.1038/s43856-023-00323-8. Commun Med (Lond). 2023. PMID: 37349499 Free PMC article. No abstract available.
Pretreatment blast-to-lymphocyte ratio as a prognostic marker for CD19/CD3-bispecific T cell-engaging antibodies (blinatumomab) treatment against relapsed or refractory B-precursor acute lymphoblastic leukemia.
Shimazu Y, Kitawaki T, Kondo T, Takaori-Kondo A. Shimazu Y, et al. Among authors: kondo t. Cancer Immunol Immunother. 2023 Nov;72(11):3861-3865. doi: 10.1007/s00262-023-03514-3. Epub 2023 Aug 7. Cancer Immunol Immunother. 2023. PMID: 37550429 Free PMC article.
Pre-transplant phase angle as a potential marker for predicting the development of infection after allogeneic hematopoietic stem cell transplantation.
Hamada R, Murao M, Asano T, Miyasaka J, Matsushita M, Kajimoto T, Otagaki A, Nankaku M, Kobayashi A, Kondo T, Arai Y, Kanda J, Takaori-Kondo A, Ikeguchi R, Matsuda S. Hamada R, et al. Among authors: kondo t. Clin Nutr ESPEN. 2023 Dec;58:122-127. doi: 10.1016/j.clnesp.2023.09.925. Epub 2023 Sep 26. Clin Nutr ESPEN. 2023. PMID: 38056995
Methotrexate-induced subacute myelopathy: a serious but treatable complication.
Miyoshi T, Kondo T, Nishikori M, Kitawaki T, Kobayashi K, Fujimoto M, Yoshinaga N, Oka S, Asagoe K, Imashuku S, Takaori-Kondo A. Miyoshi T, et al. Among authors: kondo t. J Clin Exp Hematop. 2023;63(4):251-256. doi: 10.3960/jslrt.23041. J Clin Exp Hematop. 2023. PMID: 38148015 Free PMC article.
7,618 results